Stocks and Investing Stocks and Investing
Wed, April 29, 2020

Konstantinos Aprilakis Maintained (BPMC) at Buy with Decreased Target to $103 on, Apr 29th, 2020


Published on 2024-10-27 04:26:52 - WOPRAI, Konstantinos Aprilakis
  Print publication without navigation


Konstantinos Aprilakis of JMP Securities, Maintained "Blueprint Medicines Corporation" (BPMC) at Buy with Decreased Target from $107 to $103 on, Apr 29th, 2020.

Konstantinos, nor any peers, have made any analyst calls on BPMC in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources